Cyclopharm Limited (AU:CYC) has released an update.
Cyclopharm Limited has reported a change in director John William Wigglesworth’s interest, with the acquisition of 20,979 ordinary shares on-market for a value of $29,430.19. This change, detailed in the company’s latest filing, indicates an increase in Wigglesworth’s stake in the company, with no disposals reported and no interests in contracts noted.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.
